UPB (Upstream Bio) Days Payable : 0.00 (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Upstream Bio Days Payable?

Upstream Bio's average Accounts Payable for the three months ended in Sep. 2024 was $5.23 Mil. Upstream Bio's Cost of Goods Sold for the three months ended in Sep. 2024 was $0.00 Mil.

The historical rank and industry rank for Upstream Bio's Days Payable or its related term are showing as below:

UPB's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 124.87
* Ranked among companies with meaningful Days Payable only.

Upstream Bio's Days Payable stayed the same from Jun. 2023 (0.00) to Sep. 2024 (0.00). stayed the same

Upstream Bio Days Payable Historical Data

The historical data trend for Upstream Bio's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Upstream Bio Days Payable Chart

Upstream Bio Annual Data

Trend

Dec22

Dec23

Days Payable

Upstream Bio Quarterly Data
	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Upstream Bio's Days Payable

For the Biotechnology subindustry, Upstream Bio's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Upstream Bio's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Upstream Bio's Days Payable distribution charts can be found below:

* The bar in red indicates where Upstream Bio's Days Payable falls into.

Upstream Bio Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Upstream Bio's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.712	+	1.99)	/	2 )	/	0	*	365
=	1.351					/	0	*	365
=	N/A

Upstream Bio's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (5.56	+	4.899)	/	2 )	/	0	*	365 / 4
=	5.2295					/	0	*	365 / 4
=	N/A

Upstream Bio Days Payable Related Terms

Thank you for viewing the detailed overview of Upstream Bio's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Upstream Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Upstream Bio Inc (NAS:UPB) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

890 Winter Street, Suite 200, Waltham, MA, USA, 02451

Website

https://www.upstreambio.com

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases.